Biocept (BIOC) Reports Q1 Loss of $0.61

Biocept (NASDAQ: BIOC) reported Q1 EPS of ($0.61), versus ($3.33) reported last year. Revenue for the quarter came in at $976 thousand versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform